Abstract:AbstractBackgroundThe identification of candidate biomarkers before amyloid‐ plaque deposition occurs is therefore of great importance for the early intervention of AD. Urine, which is not regulated by homeostatic mechanisms, theoretically accumulates changes associated with AD earlier than cerebrospinal fluid and blood. In this study, an APP (swe)/PSEN1dE9 transgenic mouse model was used to identify candidate biomarkers for early AD.MethodUrine samples were collected from 4‐, 6‐, and 8‐month‐old transgenic mouse models, and the urinary proteomes were profiled using liquid chromatography coupled with tandem mass spectrometry (LC‐MS/MS). The pathways related to differential urinary proteins were analyzed. Early intervention was tested based on the pathway analysis.ResultThe levels of 29 proteins differed significantly between wild type and 4‐month‐old mice, which had not started to accumulate amyloid‐ plaques. Among these proteins, 13 have been associated with the mechanisms of AD, while 9 have been suggested as AD biomarkers. The result of intervention is promising. The details will be available before the meeting.ConclusionOur results indicated that urine proteins enable detection of AD before amyloid‐ plaque deposition, which may present an opportunity for effective intervention.

Early Candidate Urine Biomarkers for Detecting Alzheimer’s Disease Before Amyloid‐plaque Deposition in an APP (swe)/psen1de9 Transgenic Mouse Model for Effective Early Intervention